SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-04-066273
Filing Date
2004-04-21
Accepted
2004-04-21 11:51:11
Documents
4
Period of Report
2004-05-20
Effectiveness Date
2004-04-21

Document Format Files

Seq Description Document Type Size
1 NOTICE AND PROXY STATEMENT ddef14a.htm DEF 14A 222010
3 GRAPHIC g46599g00o30.jpg GRAPHIC 8814
4 GRAPHIC g46599g37e23.jpg GRAPHIC 58213
5 GRAPHIC g46599g81k54.jpg GRAPHIC 18052
  Complete submission text file 0001193125-04-066273.txt   308876
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23272 | Film No.: 04744603
SIC: 2836 Biological Products, (No Diagnostic Substances)